HTL Biotechnology
Laurent Bouillaut is an experienced professional in the field of microbiology and biotechnology, currently serving as the Executive Director of Science and Technology at HTL Biotechnology since October 2023. Prior roles include Vice President of Discovery and Translational Research and Senior Director of Molecular Biology at DermBiont, Inc. Over the years, Laurent has held various positions such as Project and Business Operation Manager at Biose Industrie and Principal Scientist at DermBiont, Inc. Prior experiences also include roles as a Senior Scientist at ConsortiaTX, Inc., Program Manager and Senior Research Scientist at Matrivax R&D, and a post-doctoral associate at Tufts University, where research focused on the regulation of Stickland reactions in Clostridium difficile. Laurent's academic background includes a PhD in Microbiology from AgroParisTech and a DEA in Medical Microbiology and Bacteriology from Université de Caen Normandie.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.